LIVE FROM THE DATABASETRANSACTIONS 723,671COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 01:30 PM
Reporting ownerCIK 0002022303

Dallan Murray

13 transactions in one company, from February 11, 2025 to March 10, 2025.

Transactions
131 company
Bought · P
$0open market
Sold · S
$0open market
Net
+$0net buying

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Sarepta Therapeutics, Inc.SRPT13——

All transactions

13 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefDERIVMar 10AAward16,644$0.00—?16,644derivatives
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefDERIVMar 7MOption exercise5,500$0.00—?0derivatives
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 10AAward8,276——38,202
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 10FTax withholding2,737$100.13$274K29,926
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 10FTax withholding996$100.13$100K32,663
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 7MOption exercise5,500——33,659
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefDERIVMar 6MOption exercise17,500$0.00—?0derivatives
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 7FTax withholding8,613$103.70$893K28,159
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 7FTax withholding549$103.70$57K36,772
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 6MOption exercise17,500——37,321
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 4FTax withholding1,685$101.34$171K19,821
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefMar 3FTax withholding711$103.77$74K21,506
Sarepta Therapeutics, Inc.SRPTDallan MurrayChiefDERIVFeb 11AAward3,500$0.00—?17,500derivatives